Found: 130
Select item for more details and to access through your institution.
Is the US "leading from behind" on health policy?
- Published in:
- 2014
- By:
- Publication type:
- editorial
CHANGING FACE OF MEDICARE'S NATIONAL COVERAGE DETERMINATIONS FOR TECHNOLOGY.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?
- Published in:
- International Journal of Technology Assessment in Health Care, 2010, v. 26, n. 1, p. 71, doi. 10.1017/S0266462309990833
- By:
- Publication type:
- Article
Key principles for the improved conduct of health technology assessments for resource allocation decisions.
- Published in:
- International Journal of Technology Assessment in Health Care, 2008, v. 24, n. 3, p. 244, doi. 10.1017/S0266462308080343
- By:
- Publication type:
- Article
Diffusion of published cost-utility analyses in the field of health policy and practice.
- Published in:
- International Journal of Technology Assessment in Health Care, 2005, v. 21, n. 3, p. 399, doi. 10.1017/S026646230505052X
- By:
- Publication type:
- Article
Cross-national comparison of technology assessment processes.
- Published in:
- International Journal of Technology Assessment in Health Care, 2004, v. 20, n. 3, p. 300
- By:
- Publication type:
- Article
Bayesian value-of-information analysis. An application to a policy model of Alzheimer's disease.
- Published in:
- 2001
- By:
- Publication type:
- journal article
MEASURING COSTS IN COST-UTILITY ANALYSESVariations in the Literature.
- Published in:
- International Journal of Technology Assessment in Health Care, 2000, v. 16, n. 1, p. N.PAG, doi. 10.1017/s0266462300161100
- By:
- Publication type:
- Article
Potential Savings from Using Information Technology Applications in Health Care in the United States.
- Published in:
- International Journal of Technology Assessment in Health Care, 1996, v. 12, n. 3, p. 425, doi. 10.1017/S0266462300009788
- By:
- Publication type:
- Article
Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 Pandemic.
- Published in:
- PharmacoEconomics, 2021, v. 39, n. 11, p. 1201, doi. 10.1007/s40273-021-01088-5
- By:
- Publication type:
- Article
Correction to: Perspective and Costing in Cost‑Effectiveness Analysis, 1974–2018.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Perspective and Costing in Cost-Effectiveness Analysis, 1974-2018.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: Publication of Decision Model Source Code: Attitudes of Health Economics Authors.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
Publication of Decision Model Source Code: Attitudes of Health Economics Authors.
- Published in:
- 2019
- By:
- Publication type:
- letter
Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer's Disease Interventions.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ICER's Revised Value Assessment Framework for 2017-2019: A Critique.
- Published in:
- 2017
- By:
- Publication type:
- letter
Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Review of the Costs and Cost Effectiveness of Interventions in Chronic Kidney Disease: Implications for Policy.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 10, p. 839, doi. 10.2165/11588390-000000000-00000
- By:
- Publication type:
- Article
US FDA Modernization Act, Section 114: Uses, Opportunities and Implications for Comparative Effectiveness Research.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 8, p. 687, doi. 10.2165/11590510-000000000-00000
- By:
- Publication type:
- Article
30 Years of Pharmaceutical Cost-Utility Analyses: Growth, Diversity and Methodological Improvement.
- Published in:
- PharmacoEconomics, 2009, v. 27, n. 10, p. 861, doi. 10.2165/11312720-000000000-00000
- By:
- Publication type:
- Article
Valuing children's health: a comparison of cost-utility analyses for adult and paediatric health interventions in the US.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Valuing Children's Health.
- Published in:
- PharmacoEconomics, 2007, v. 25, n. 10, p. 817, doi. 10.2165/00019053-200725100-00002
- By:
- Publication type:
- Article
Economic evaluation in the US: what is the missing link?
- Published in:
- 2006
- By:
- Publication type:
- journal article
Health utilities in Alzheimer's disease and implications for cost-effectiveness analysis.
- Published in:
- 2005
- By:
- Publication type:
- journal article
How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions?
- Published in:
- 2004
- By:
- Publication type:
- journal article
Patient and Caregiver Views on Measures of the Value of Health Interventions.
- Published in:
- Patient Preference & Adherence, 2022, v. 16, p. 3383, doi. 10.2147/PPA.S390227
- By:
- Publication type:
- Article
Lack of Cost-Effectiveness Analyses to Address Healthy People 2020 Priority Areas.
- Published in:
- American Journal of Public Health, 2016, v. 106, n. 12, p. 2205, doi. 10.2105/AJPH.2016.303361
- By:
- Publication type:
- Article
NEUMANN ETAL RESPOND.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Measuring the Value of Public Health Systems: The Disconnect Between Health Economists and Public Health Practitioners.
- Published in:
- American Journal of Public Health, 2008, v. 98, n. 12, p. 2173, doi. 10.2105/AJPH.2007.127134
- By:
- Publication type:
- Article
To Your Health: How to Understand What Research Tells Us About Risk.
- Published in:
- 2005
- By:
- Publication type:
- Book Review
Liability for Adverse Events in Direct-to-Consumer Advertising—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 289, n. 20, p. 2646, doi. 10.1001/jama.289.20.2646-a
- By:
- Publication type:
- Article
Direct-to-Consumer Advertising and Shared Liability for Pharmaceutical Manufacturers.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 289, n. 4, p. 477, doi. 10.1001/jama.289.4.477
- By:
- Publication type:
- Article
Follow-On Indications for Orphan Drugs Related to the Inflation Reduction Act.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 8, p. e2329006, doi. 10.1001/jamanetworkopen.2023.29006
- By:
- Publication type:
- Article
Participation in the qualified Medicare Beneficiary program.
- Published in:
- Health Care Financing Review, 1995, v. 17, n. 2, p. 169
- By:
- Publication type:
- Article
A review of HTA guidelines on societal and novel value elements.
- Published in:
- International Journal of Technology Assessment in Health Care, 2023, v. 39, n. 1, p. 1, doi. 10.1017/S026646232300017X
- By:
- Publication type:
- Article
Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Health technology assessment for gene therapies in haemophilia.
- Published in:
- Haemophilia, 2022, v. 28, p. 19, doi. 10.1111/hae.14413
- By:
- Publication type:
- Article
Attitudes on Equal Health Care Access versus Efficient Clinical Decisions across a Not-for-Profit Health Care System.
- Published in:
- Medical Decision Making, 2024, v. 44, n. 1, p. 18, doi. 10.1177/0272989X231206750
- By:
- Publication type:
- Article
Analyzing the Cost Effectiveness of Policy Responses for COVID-19: The Importance of Capturing Social Consequences.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Future Directions for Cost-effectiveness Analyses in Health and Medicine.
- Published in:
- Medical Decision Making, 2018, v. 38, n. 7, p. 767, doi. 10.1177/0272989X18798833
- By:
- Publication type:
- Article
Patient Variability Seldom Assessed in Cost-effectiveness Studies.
- Published in:
- Medical Decision Making, 2018, v. 38, n. 4, p. 487, doi. 10.1177/0272989X17746989
- By:
- Publication type:
- Article
Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction Models.
- Published in:
- Medical Decision Making, 2017, v. 37, n. 7, p. 790, doi. 10.1177/0272989X17704855
- By:
- Publication type:
- Article
The Role of Decision Models in Health Care Policy.
- Published in:
- Medical Decision Making, 2016, v. 36, n. 5, p. 666, doi. 10.1177/0272989X16646732
- By:
- Publication type:
- Article
How Long and How Well: Oncologists’ Attitudes Toward the Relative Value of Life-Prolonging v. Quality of Life-Enhancing Treatments.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
How Long and How Well: Oncologists’ Attitudes Toward the Relative Value of Life-Prolonging v. Quality of Life-Enhancing Treatments.
- Published in:
- Medical Decision Making, 2011, v. 31, n. 3, p. 380, doi. 10.1177/0272989X10385847
- By:
- Publication type:
- Article
Does Medicare Have an Implicit Cost-Effectiveness Threshold?
- Published in:
- Medical Decision Making, 2010, v. 30, n. 4, p. E14, doi. 10.1177/0272989X10371134
- By:
- Publication type:
- Article
A Bibliometric Review of Cost-Effectiveness Analyses in the Economic and Medical Literature: 1976-2006.
- Published in:
- Medical Decision Making, 2010, v. 30, n. 3, p. 320, doi. 10.1177/0272989X09360066
- By:
- Publication type:
- Article
The Adoption of Cost-Effectiveness Acceptability Curves in Cost-Utility Analyses.
- Published in:
- Medical Decision Making, 2010, v. 30, n. 3, p. 314, doi. 10.1177/0272989X09344749
- By:
- Publication type:
- Article
Quality of Abstracts of Papers Reporting Original Cost-Effectiveness Analyses.
- Published in:
- Medical Decision Making, 2005, v. 25, n. 4, p. 424, doi. 10.1177/0272989X05278932
- By:
- Publication type:
- Article
Can We Better Prioritize Resources for Cost-Utility Research?
- Published in:
- Medical Decision Making, 2005, v. 25, n. 4, p. 429, doi. 10.1177/0272989X05276853
- By:
- Publication type:
- Article